Covaxin triggers immune response, no side effects
December 16, 2020 20:26
Bharat Biotech's coronavirus vaccine candidate 'Covaxin' induced an immune response and registered no serious adverse events, interim findings of trials have revealed.
Phase I and Phase II results have shown that the vaccine was well tolerated in all groups the data showed.
Bharat Biotech said Covaxin showed robust immune response with no side-effects.